Chronic myeloproliferative disorders are polycythaemia vera, primary thrombocythaemia, and chronic myeloid (or The subgroup with diffusely distributed giant megakaryocytes comes closer to chronic myeloid leukaemia, the cluster subgroup to primary thrombocythaemia. Table 8 shows the mean blood cell values of the major subgroups. This shows that the histological manifestations of untreated cases generally correspond to characteristic blood cell counts. Table 9 gives a more differentiated test of the haematological validity of the histological subgroups. There was a good correlation between the histological erythrocytic proliferation and granulocytic proliferation groups and their haematological expression, typical of polycythaemia vera and chronic myeloid leukaemia, Table 10 Correlations of clincal data for age and sex: respectively. It should be noted, however, that erythrocytosis and leukaemia also occur in a small proportion of all the other groups. Giant cell megakaryocytic myelosis and thrombocythaemia, the typical combination found in primary thrombocythaemia, are also clearly correlated, although thrombocythaemia (>700 x 109/l) is found in the other groups also (for example in 50% of Meg-GdGran-M). The mixed megakaryocytic-granulocytic proliferation groups are clearly distinguished from each other. Pancytopenia was almost as common in the groups of megakaryocytic-I/P-M, myelofibrosis, osteomyelosclerosis, and blast crisis, although minor percentages of these groups exhibit erythraemia, leukaemia and thrombocythaemia. The incidence of Grade 1 myelofibrosis and osteomyelosclerosis were included in the corresponding histological subgroups in which the following percentages were found: erythrocytic proliferation-M 6% and 2%, respectively; granulocytic proliferation-M 7% and 0%, respectively; megakaryocytic proliferation-G-M 7% and 2%, respectively; megakaryocytic proliferation-Gdgranulocytic proliferation-M 5% and 5%, respectively; megakaryocytic proliferation-Gc-Granulocytic proliferation-M 35% and 4%, respectively; megakaryocytic-I/P-M 45% and 7%, respectively; blast crisis 51% and 16%, respectively. These figures show that in all subgroups minor grades of myelofibrosis are much more common than osteomyelosclerosis, the highest percentages of myelofibrosis and osteomyelosclerosis occurring in the cluster variant of mixed megakaryo-cyticgranulocytic myelosis, and in the immature and pleomorphic megakaryocytic and blastic subgroups.
STATISTICAL EVALUATION OF CLINICAL AND HISTOLOGICAL CRITERIA
Correlations between clinical and histological data 249 were statistically checked (Table 10) . Especially noteworthy were: the mean age, which was higher in myelofibrosis than in osteomyelosclerosis; the fact that women predominate in the groups with thrombocythaemia; splenomegaly was more common in the megakaryocytic-granulocytic proliferation group in which there were clusters rather than diffusely distributed megakaryocytes, and was also commoner in myelofibrosis/osteomyelosclerosis than in the rest of chronic myeloproliferative disorders. Significant differences of survival Erythrocytic proliferation-M Granulocytic proliferation-M Erythrocytic proliferation-M Megakaryocytic proliferation-Gc-granulocytic proliferation-M Erythrocytic proliferation-M Megakaryocytic proliferation-Gd-granulocytic proliferation-M Granulocytic proliferation-M Megakaryocytic proliferation-G-M myelofibrosis/osteomyelosclerosis or blast crisis. The remaining third of the cases defined according to their histology showing blastic proliferation, or myelofibrosis/osteomyelosclerosis, or a combination of both, were therefore considered to be the transformed stages of chronic myeloproliferative disorders. In each of these three groups different types and forms of distribution of megakaryocytic proliferation predominated (Table 13) .
These results lead to the formulation of a working classification (Table 13) consisting of three main categories. The subgroups were distinguished by the proliferating cell lines, their maturity, the degree of fibrosis and osteosclerosis, the distribution and cytological types of megakaryocytes, and the degree of efficient platelet production. This working classification includes all structural forms found in chronic myeloproliferative disorders, together with their initial haematological and clinical correlations. 252 proliferation in neoplasias of the two other cell lines adversely influences the course of chronic myeloproliferative disorders, mainly towards blast crisis.14 Megakaryocytic pathology has a role of its own in chronic myeloproliferative disorders. The dwarf type is characteristic of granulocytic proliferation-M (chronic myeloid leukaemia), with a tendency to develop into immature forms.3 The occurrence of sheets is related to immature and pleomorphic megakaryocytes and thrombocytopenia. The incidence of the combination of fibrotic and blastic changes (equivalent to "acute myelosclerosis" in many cases) points to a closely related pathogenesis. The giant type of megakaryocyte occurs with increased megakaryocytopoiesis, especially in polycythaemia vera, primary thrombocythaemia, and megakaryocytic granulocytic proliferation-M. The diffuse form of the megakaryocytic granulocytic proliferation-M is prone to subleukaemic changes and splenomegaly, whereas the cluster form tends towards thrombocythaemia and myelofibrosis, due in part to interstitial deposits of platelets and interstitial degeneration of megakaryocytes.
The results of this study lead to a closer correlation of the different histological and haematological expressions of chronic myeloproliferative disorders; to a better definition of the atypical forms; and to the integration of all entities into a proposed classification that indicates the place of each group in the sequence of the myeloproliferative processes and their transformations. With this working classification it will be possible to classify an individual patient with chronic myeloproliferative disorders more clearly and in doing so coordinate as much information as possible from all other sources.
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